4 Nov 2022 , 01:36 PM
Net profit of Hester Biosciences declined 34.65% to Rs 6.94 crore in the quarter ended September 2022 as against Rs 10.62 crore during the previous quarter ended September 2021. Sales rose 16.74% to Rs 73.15 crore in the quarter ended September 2022 as against Rs 62.66 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 73.15 | 62.66 | 17 |
| OPM % | 17.43 | 28.02 | – |
| PBDT | 15.30 | 18.24 | -16 |
| PBT | 10.27 | 15.19 | -32 |
| NP | 6.94 | 10.62 | -35 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
